YBS supports the bioanalysis of therapeutic biological entities, and the analysis of biomarkers, using immunoassay techniques (ELISA, Gyrolab, ECL), routinely supporting extensive preclinical and clinical development programmes (PK and ADA analysis).
We can also offer development of immunoassay based methods, as well as expert advice on the selection of appropriate biomarkers for specific therapeutic areas. Our sister company, Unilabs in Copenhagen, is able to offer an extensive list of important biomarker assays off-the-shelf. Please contact us for more information, or to receive an up-to-date list of available biomarkers.